Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Open Access Site Shares Microbial Genome Data

By LabMedica International staff writers
Posted on 24 Nov 2008
Whole genome sequences of the microbes Escherichia coli, Staphylococcus aureus, and Rhodobacter sphaeroides were released in sample datasets on an open-access website. More...


The bacteria were sequenced with consensus accuracies greater than 99.995%. Each sample dataset, containing between six and 12 million aligned reads, was generated from one channel of a 50-channel run on the HeliScope Single Molecule Sequencer.

The open access site for sharing data sets and bioinformatics software tools is called the HeliSphere Technology Center. It was launched by Helicos BioSciences Corporation (Cambridge, MA, USA) during the 58th annual meeting of the American Society of Human Genetics. The meeting took place in Philadelphia (PA, USA) on November 13-15, 2008.

Data from a number of sequencing projects currently underway will be posted on the HeliSphere Technology Center Web site on a regular basis. In addition to Helicos data sets, the new Web site is also a gateway to Helicos' open source project, which includes downloadable source code and software documentation.

"The open access site benefits customers and software developers, as well as the wider scientific community by making not only datasets, but source code and support tools easily accessible," commented Helicos CEO Steve Lombardi.

Helicos BioSciences is a life science company focused on genetic analysis technologies for the diagnostic, research, and drug discovery markets. Helicos' proprietary True Single Molecule Sequencing (tSMS) technology allows direct measurement of billions of strands of DNA, enabling scientists to perform experiments and ask questions that were not possible in the past.

Related Links:
HeliSphere Technology Center
Helicos BioSciences Corporation




Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.